Skip to content

The Use of Platelet-rich-fibrin in Lower Third Molar Surgery.

The Use of Platelet-rich-fibrin in Lower Third Molar Surgery: a Split-mouth Randomized Clinical Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06165692
Enrollment
31
Registered
2023-12-11
Start date
2022-10-01
Completion date
2023-10-31
Last updated
2023-12-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Facial Swelling, Tooth Avulsion, Tooth Extraction Status Nos, Tooth, Impacted, Tooth Position Anomalies

Keywords

third molar surgery, facial swelling, 3D facial swelling evaluation, PRF, tooth impacted, platelet rich fibrin

Brief summary

The present study aims to analyze the effect of PRF (Platelet-rich-fibrin) in terms of facial swelling, trismus and pain after surgical removal of mandibular third molar (M3M) in a split-mouth randomized controlled clinical trial.

Detailed description

The present study aims to analyze the effect of PRF (Platelet-rich-fibrin) in terms of facial swelling, trismus and pain after surgical removal of mandibular third molar (M3M) in a split-mouth randomized controlled clinical trial. Facial swelling will be assessed using an innovative three-dimensional digital technique.

Interventions

BIOLOGICALPRF

Post-operative PRF placement in the post-extraction socket after third molar surgery

Sponsors

Amerigo Giudice
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Caregiver, Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to 32 Years
Healthy volunteers
Yes

Inclusion criteria

* Patients aged 18 to 32 years who required both M3M extractions were recruited * Good health status * Indication to surgical extraction of both M3M * Complete root formation * Surgical risk level classified as Conventional or Moderate according to Daugela et al. classification

Exclusion criteria

* Person under the age of 18 or over 32 * Allergy or contraindications to administration of corticosteroids * Acute infection in any of the teeth to be extracted * Patients with chronic liver disease, diabetes, immune system dysfunction, or haematological disease * Pregnancy or breastfeeding * History of treatment with antiresorptive drugs * Chronic kidney disease

Design outcomes

Primary

MeasureTime frameDescription
Facial swelling qualitative analysisChange from baseline (before surgery) at 2 day after surgery and at 7 days after surgeryTo compare the effectiveness of PRF in reducing facial swelling using qualitative three-dimensional analysis (measured by colorimetric variation given by the overlapping volumes) .
Facial swelling quantitative analysis - volumetric differencesChange from baseline (before surgery) at 2 day after surgery and at 7 days after surgeryTo compare the effectiveness of PRF in reducing facial swelling using quantitative three-dimensional analysis ( volumes measured in cm3) .
Facial swelling quantitative analysis - linear differencesChange from baseline (before surgery) at 2 day after surgery and at 7 days after surgeryTo compare the effectiveness of PRF in reducing facial swelling using quantitative three-dimensional analysis (linear differences measured in cm2) .

Secondary

MeasureTime frameDescription
Trismus analysisChange from baseline (before surgery) at 2 day after surgery and at 7 days after surgeryTo assess the effects of PRF administration on trismus (measured in cm)
Pain analysis with Visual analogue scale (VAS)Change from baseline (before surgery) at 2 day after surgery and at 7 days after surgeryTo assess the effects of PRF administration on pain (measured by VAS-score from 0 to 10 point, with 10 as the worst outcome)

Countries

Italy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026